메뉴 건너뛰기




Volumn 17, Issue 1, 2007, Pages 147-152

Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia

Author keywords

Acute leukemia; Angiogenesis; Children; Inducible nitric oxide synthase; Prognosis; VEGF

Indexed keywords

ANGIOGENIC PROTEIN; FIBROBLAST GROWTH FACTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; VASCULOTROPIN C;

EID: 39049188003     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.147     Document Type: Article
Times cited : (10)

References (61)
  • 1
    • 0028929803 scopus 로고
    • Angiogenesis in cancer, vascular, rheumatoid and other disease
    • Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
    • (1995) Nat Med , vol.1 , pp. 27-31
    • Folkman, J.1
  • 2
    • 0030448814 scopus 로고    scopus 로고
    • Blood vessel formation: What is its molecular basis?
    • DOI 10.1016/S0092-8674(00)81810-3
    • Folkman J and D'Amore PA: Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155, 1996. (Pubitemid 27010098)
    • (1996) Cell , vol.87 , Issue.7 , pp. 1153-1155
    • Folkman, J.1    D'Amore, P.A.2
  • 3
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 4
    • 84975525035 scopus 로고
    • Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
    • Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
    • (1995) N Engl J Med , vol.333 , pp. 1757-1763
    • Folkman, J.1
  • 5
    • 0026446102 scopus 로고
    • Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
    • Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
    • (1992) Nature , vol.359 , pp. 845-848
    • Plate, K.H.1    Breier, G.2    Weich, H.A.3    Risau, W.4
  • 6
    • 0031106404 scopus 로고    scopus 로고
    • Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
    • Pepper MS: Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21-43, 1997.
    • (1997) Cytokine Growth Factor Rev , vol.8 , pp. 21-43
    • Pepper, M.S.1
  • 9
    • 0025999033 scopus 로고
    • The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
    • Tischer E, Mitchell R, Hartman T, et al: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
    • (1991) J Biol Chem , vol.266 , pp. 11947-11954
    • Tischer, E.1    Mitchell, R.2    Hartman, T.3
  • 12
    • 0033485961 scopus 로고    scopus 로고
    • Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
    • Aguayo A, Estey E, Kantarjian H, et al: Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94: 3717-3721, 1999.
    • (1999) Blood , vol.94 , pp. 3717-3721
    • Aguayo, A.1    Estey, E.2    Kantarjian, H.3
  • 13
    • 0034665786 scopus 로고    scopus 로고
    • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
    • Aguayo A, Kantarjian H, Manshouri T, et al: Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96: 2240-2245, 2000.
    • (2000) Blood , vol.96 , pp. 2240-2245
    • Aguayo, A.1    Kantarjian, H.2    Manshouri, T.3
  • 14
    • 0033806603 scopus 로고    scopus 로고
    • The thin red line: Angiogenesis in normal and malignant hematopoiesis
    • Bertolini F, Mancuso P, Gobbi A and Pruneri G: The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol 28: 993-1000, 2000.
    • (2000) Exp Hematol , vol.28 , pp. 993-1000
    • Bertolini, F.1    Mancuso, P.2    Gobbi, A.3    Pruneri, G.4
  • 15
    • 0031784561 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
    • DOI 10.1002/(SICI)1097-4652(199812)177:3<439::A
    • Pepper MS, Mandriota SJ, Jeltsch M, Kumar V and Alitalo K: Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol 177: 439-452, 1998. (Pubitemid 28524667)
    • (1998) Journal of Cellular Physiology , vol.177 , Issue.3 , pp. 439-452
    • Pepper, M.S.1    Mandriota, S.J.2    Jeltsch, M.3    Kumar, V.4    Alitalo, K.5
  • 16
    • 0037085765 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy
    • DOI 10.1182/blood.V99.6.2179
    • Dias S, Choy M, Alitalo K and Rafii S: Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99: 2179-2184, 2002. (Pubitemid 34525504)
    • (2002) Blood , vol.99 , Issue.6 , pp. 2179-2184
    • Dias, S.1    Choy, M.2    Alitalo, K.3    Rafii, S.4
  • 17
    • 0028115003 scopus 로고
    • Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
    • Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994. (Pubitemid 24325027)
    • (1994) Japanese Journal of Cancer Research , vol.85 , Issue.10 , pp. 1045-1049
    • Toi, M.1    Hoshina, S.2    Takayanagi, T.3    Tominaga, T.4
  • 18
    • 84970070220 scopus 로고
    • Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
    • Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
    • (1995) Cancer Res , vol.55 , pp. 3964-3968
    • Takahashi, Y.1    Kitadai, Y.2    Bucana, C.D.3    Cleary, K.R.4    Ellis, L.M.5
  • 19
    • 0035865450 scopus 로고    scopus 로고
    • Clinical implications of circulating angiogenic factors in cancer patients
    • Poon RT, Fan ST and Wong J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19: 1207-1225, 2001. (Pubitemid 32176299)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.4 , pp. 1207-1225
    • Poon, R.T.-P.1    Fan, S.-T.2    Wong, J.3
  • 20
    • 0030797765 scopus 로고    scopus 로고
    • A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
    • Salven P, Teerenhovi L and Joensuu H: A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90: 3167-3172, 1997. (Pubitemid 27444212)
    • (1997) Blood , vol.90 , Issue.8 , pp. 3167-3172
    • Salven, P.1    Teerenhovi, L.2    Joensuu, H.3
  • 21
    • 0034548821 scopus 로고    scopus 로고
    • Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: A single-institution study of 200 patients
    • Salven P, Orpana A, Teerenhovi L and Joensuu H: Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 96: 3712-3718, 2000.
    • (2000) Blood , vol.96 , pp. 3712-3718
    • Salven, P.1    Orpana, A.2    Teerenhovi, L.3    Joensuu, H.4
  • 22
    • 0032705222 scopus 로고    scopus 로고
    • Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
    • Molica S, Vitelli G, Levato D, Gandolfo GM and Liso V: Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 107: 605-610, 1999.
    • (1999) Br J Haematol , vol.107 , pp. 605-610
    • Molica, S.1    Vitelli, G.2    Levato, D.3    Gandolfo, G.M.4    Liso, V.5
  • 24
    • 0034090097 scopus 로고    scopus 로고
    • Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
    • Griffioen AW and Molema G: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268, 2000. (Pubitemid 30368433)
    • (2000) Pharmacological Reviews , vol.52 , Issue.2 , pp. 237-268
    • Griffioen, A.W.1    Molema, G.2
  • 29
    • 29044435272 scopus 로고    scopus 로고
    • Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies
    • Ribatti D and Vacca A: Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies. Curr Cancer Drug Targets 5: 573-578, 2005. (Pubitemid 41789597)
    • (2005) Current Cancer Drug Targets , vol.5 , Issue.8 , pp. 573-578
    • Ribatti, D.1    Vacca, A.2
  • 31
    • 1642321097 scopus 로고    scopus 로고
    • Evaluating Antiangiogenesis Agents in the Clinic: The Eastern Cooperative Oncology Group Portfolio of Clinical Trials
    • DOI 10.1158/1078-0432.CCR-03-0238
    • Sparano JA, Gray R, Giantonio B, O'Dwyer P and Comis RL: Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Clin Cancer Res 10: 1206-1211, 2004. (Pubitemid 38365208)
    • (2004) Clinical Cancer Research , vol.10 , Issue.4 , pp. 1206-1211
    • Sparano, J.A.1    Gray, R.2    Giantonio, B.3    O'Dwyer, P.4    Comis, R.L.5
  • 32
    • 0034523201 scopus 로고    scopus 로고
    • Co-operative study group for childhood acute lymphoblastic leukemia (COALL): Long-term follow-up of trials 82, 85, 89 and 92
    • DOI 10.1038/sj.leu.2401974
    • Harms DO and Janka-Schaub GE: Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14: 2234-2239, 2000. (Pubitemid 32042264)
    • (2000) Leukemia , vol.14 , Issue.12 , pp. 2234-2239
    • Harms, D.O.1    Janka-Schaub, G.E.2
  • 33
    • 0023277545 scopus 로고
    • Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
    • DOI 10.1006/abio.1987.9999
    • Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
    • (1987) Analytical Biochemistry , vol.162 , Issue.1 , pp. 156-159
    • Chomczynski, P.1    Sacchi, N.2
  • 34
    • 0033957420 scopus 로고    scopus 로고
    • Evidence of increased angiogenesis in patients with acute myeloid leukemia
    • Hussong JW, Rodgers GM and Shami PJ: Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95: 309-313, 2000. (Pubitemid 30017257)
    • (2000) Blood , vol.95 , Issue.1 , pp. 309-313
    • Hussong, J.W.1    Rodgers, G.M.2    Shami, P.J.3
  • 35
    • 0030933923 scopus 로고    scopus 로고
    • Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
    • Fiedler W, Graeven U, Ergun S, et al: Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89: 1870-1875, 1997. (Pubitemid 27132100)
    • (1997) Blood , vol.89 , Issue.6 , pp. 1870-1875
    • Fiedler, W.1    Graeven, U.2    Ergun, S.3    Verago, S.4    Kilic, N.5    Stockschlader, M.6    Hossfeld, D.K.7
  • 36
    • 0034604110 scopus 로고    scopus 로고
    • Role of transforming growth factor beta in human disease
    • DOI 10.1056/NEJM200005043421807
    • Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
    • (2000) New England Journal of Medicine , vol.342 , Issue.18 , pp. 1350-1358
    • Blobe, G.C.1    Schiemann, W.P.2    Lodish, H.F.3
  • 37
    • 0035689762 scopus 로고    scopus 로고
    • Malignant cells, directors of the malignant process: Role of transforming growth factor-beta
    • Teicher BA: Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 20: 133-143, 2001.
    • (2001) Cancer Metastasis Rev , vol.20 , pp. 133-143
    • Teicher, B.A.1
  • 38
    • 0035153463 scopus 로고    scopus 로고
    • Role of transforming growth factor beta in cancer
    • Pasche B: Role of transforming growth factor beta in cancer. J Cell Physiol 186: 153-168, 2001.
    • (2001) J Cell Physiol , vol.186 , pp. 153-168
    • Pasche, B.1
  • 39
    • 0035175418 scopus 로고    scopus 로고
    • Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia
    • DOI 10.1159/000046596
    • Brandao MM, Soares E, Salles TS and Saad ST: Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia. Acta Haematol 106: 95-99, 2001. (Pubitemid 33079263)
    • (2001) Acta Haematologica , vol.106 , Issue.3 , pp. 95-99
    • Brandao, M.M.1    Soares, E.2    Salles, T.S.I.3    Saad, S.T.O.4
  • 40
    • 0032147236 scopus 로고    scopus 로고
    • B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
    • Zhao H, Dugas N, Mathiot C, et al: B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92: 1031-1043, 1998. (Pubitemid 28355488)
    • (1998) Blood , vol.92 , Issue.3 , pp. 1031-1043
    • Zhao, H.1    Dugas, N.2    Mathiot, C.3    Delmer, A.4    Dugas, B.5    Sigaux, F.6    Kolb, J.-P.7
  • 41
    • 0033898269 scopus 로고    scopus 로고
    • Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity
    • Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J and Palmblad J: Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 157: 15-19, 2000. (Pubitemid 30641719)
    • (2000) American Journal of Pathology , vol.157 , Issue.1 , pp. 15-19
    • Lundberg, L.G.1    Lerner, R.2    Sundelin, P.3    Rogers, R.4    Folkman, J.5    Palmblad, J.6
  • 42
    • 0028967690 scopus 로고
    • Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells
    • Allouche M, Bayard F, Clamens S, Fillola G, Sie P and Amalric F: Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 9: 77-86, 1995.
    • (1995) Leukemia , vol.9 , pp. 77-86
    • Allouche, M.1    Bayard, F.2    Clamens, S.3    Fillola, G.4    Sie, P.5    Amalric, F.6
  • 43
    • 0033083962 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
    • Bellamy WT, Richter L, Frutiger Y and Grogan TM: Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59: 728-733, 1999. (Pubitemid 29076074)
    • (1999) Cancer Research , vol.59 , Issue.3 , pp. 728-733
    • Bellamy, W.T.1    Richter, L.2    Frutiger, Y.3    Grogan, T.M.4
  • 44
    • 0025291743 scopus 로고
    • In situ detection of basic fibroblast growth factor by highly specific antibodies
    • Schulze-Osthoff K, Risau W, Vollmer E and Sorg C: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137: 85-92, 1990. (Pubitemid 20229591)
    • (1990) American Journal of Pathology , vol.137 , Issue.1 , pp. 85-92
    • Schulze-Osthoff, K.1    Risau, W.2    Vollmer, E.3    Sorg, C.4
  • 48
    • 0032400862 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
    • Gabrilovich D, Ishida T, Oyama T, et al: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92: 4150-4166, 1998. (Pubitemid 28544331)
    • (1998) Blood , vol.92 , Issue.11 , pp. 4150-4166
    • Gabrilovich, D.1    Ishida, T.2    Oyama, T.3    Ran, S.4    Kravtsov, V.5    Nadaf, S.6    Carbone, D.P.7
  • 50
    • 0026034432 scopus 로고
    • Role of nitric oxide synthesis in macrophage antimicrobial activity
    • Nathan CF and Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70, 1991.
    • (1991) Curr Opin Immunol , vol.3 , pp. 65-70
    • Nathan, C.F.1    Hibbs Jr., J.B.2
  • 51
    • 0034769118 scopus 로고    scopus 로고
    • Nitric oxide and the immune response
    • Bogdan C: Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
    • (2001) Nat Immunol , vol.2 , pp. 907-916
    • Bogdan, C.1
  • 52
    • 0033968432 scopus 로고    scopus 로고
    • The role of nitric oxide in innate immunity
    • DOI 10.1034/j.1600-065X.2000.917307.x
    • Bogdan C, Rollinghoff M and Diefenbach A: The role of nitric oxide in innate immunity. Immunol Rev 173: 17-26, 2000. (Pubitemid 30095207)
    • (2000) Immunological Reviews , vol.173 , pp. 17-26
    • Bogdan, C.1    Rollinghoff, M.2    Diefenbach, A.3
  • 53
    • 0025860655 scopus 로고
    • Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells
    • Li LM, Kilbourn RG, Adams J and Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 2531-2535, 1991.
    • (1991) Cancer Res , vol.51 , pp. 2531-2535
    • Li, L.M.1    Kilbourn, R.G.2    Adams, J.3    Fidler, I.J.4
  • 54
    • 0007733268 scopus 로고    scopus 로고
    • Induction of nitric oxide production by natural killer cells: Its role in tumor cell death
    • DOI 10.1006/niox.1999.0243
    • Jyothi MD and Khar A: Induction of nitric oxide production by natural killer cells: its role in tumor cell death. Nitric Oxide 3: 409-418, 1999. (Pubitemid 29531868)
    • (1999) Nitric Oxide - Biology and Chemistry , vol.3 , Issue.5 , pp. 409-418
    • Jyothi, M.D.1    Khar, A.2
  • 55
    • 0027958098 scopus 로고
    • Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells
    • Dong Z, Staroselsky AH, Qi X, Xie K and Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793, 1994. (Pubitemid 24068338)
    • (1994) Cancer Research , vol.54 , Issue.3 , pp. 789-793
    • Dong, Z.1    Staroselsky, A.H.2    Qi, X.3    Xie, K.4    Fidler, I.J.5
  • 56
    • 0028929559 scopus 로고
    • Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells
    • Xie K, Huang S, Dong Z, et al: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995.
    • (1995) J Exp Med , vol.181 , pp. 1333-1343
    • Xie, K.1    Huang, S.2    Dong, Z.3
  • 57
    • 0032503018 scopus 로고    scopus 로고
    • Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene
    • Juang SH, Xie K, Xu L, et al: Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther 9: 845-854, 1998. (Pubitemid 28197371)
    • (1998) Human Gene Therapy , vol.9 , Issue.6 , pp. 845-854
    • Juang, S.-H.1    Xie, K.2    Xu, L.3    Shi, Q.4    Wang, Y.5    Yoneda, J.6    Fidler, I.J.7
  • 59
  • 60
    • 0028917191 scopus 로고
    • Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
    • Genaro AM, Hortelano S, Alvarez A, Martinez C and Bosca L: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95: 1884-1890, 1995.
    • (1995) J Clin Invest , vol.95 , pp. 1884-1890
    • Genaro, A.M.1    Hortelano, S.2    Alvarez, A.3    Martinez, C.4    Bosca, L.5
  • 61
    • 0031416664 scopus 로고    scopus 로고
    • Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide
    • DOI 10.1006/niox.1997.0133
    • Dimmeler S and Zeiher AM: Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275-281, 1997. (Pubitemid 28078114)
    • (1997) Nitric Oxide - Biology and Chemistry , vol.1 , Issue.4 , pp. 275-281
    • Dimmeler, S.1    Zeiher, A.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.